0001104659-23-006184.txt : 20230124
0001104659-23-006184.hdr.sgml : 20230124
20230124160500
ACCESSION NUMBER: 0001104659-23-006184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230120
FILED AS OF DATE: 20230124
DATE AS OF CHANGE: 20230124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brenner Martin
CENTRAL INDEX KEY: 0001770235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35023
FILM NUMBER: 23548175
MAIL ADDRESS:
STREET 1: C/O PFENEX INC.
STREET 2: 10790 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: iBio, Inc.
CENTRAL INDEX KEY: 0001420720
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262797813
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 600 MADISON AVENUE, SUITE 1601
CITY: NEW YORK
STATE: NY
ZIP: 10022-1737
BUSINESS PHONE: 302 355-0650
MAIL ADDRESS:
STREET 1: 600 MADISON AVENUE, SUITE 1601
CITY: NEW YORK
STATE: NY
ZIP: 10022-1737
FORMER COMPANY:
FORMER CONFORMED NAME: iBioPharma, Inc.
DATE OF NAME CHANGE: 20080806
FORMER COMPANY:
FORMER CONFORMED NAME: InB:Biotechnologies, Inc.
DATE OF NAME CHANGE: 20071210
4
1
tm234222-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-01-20
0
0001420720
iBio, Inc.
IBIO
0001770235
Brenner Martin
C/O IBIO, INC., 8800 HSC PARKWAY
BRYAN
TX
77807
0
1
0
0
Interim CEO and CSO
Common Stock
2023-01-20
4
A
0
130000
0
A
225348
D
Consists of 130,000 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 130,000 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 130,000 RSUs vest pro rata over a twelve- month period, such vesting to terminate if Dr. Brenner is no longer the Company's Interim Chief Executive Officer.
/s/ Martin Brenner
2023-01-24